IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Trident Lifeline IPO is a Fixed Price listing on BSE SME exchange. The company is based in Surat and caters to Pharmaceutical sector. Beeline Capital Advisors is the merchant banker of Trident Lifeline IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 1st August 2022.
Trident Lifeline IPO posted revenues of ₹ 22.37 crores and PAT of ₹ 2.27 crores in FY00 on annualised basis.
Revenue:
₹ 21.77 Cr.
EBITDA Margin:
12.68
% 
Net Worth: ₹ 4.81 Cr.
Market Capitalisation:
₹ 116.14 Cr.
P/E:
51.53 times
P/BV: 2.89 times
EV/EBITDA: 42.92 times
Financial results of Trident Lifeline IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY22 | FY21 | FY20 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 13.86 | 11.44 | 6.39 | ||
| Net Worth | 4.81 | -0.47 | -3.00 | ||
| Total Debt | 2.45 | 4.53 | 6.46 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
21.77 | 9.62 | 4.93 | ||
EBITDA
EBITDA on annualised basis |
2.76 | 1.24 | -0.28 | ||
PAT
PAT on annualised basis |
2.27 | 9.78 | 5.01 | ||
Trident Lifeline IPO PAT Margin is 10.43 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Trident Lifeline IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY22 | FY21 | FY20 |
|---|---|---|---|
| EBITDA Margin (%) | 12.68 | 12.89 | -5.68 |
| PAT Margin (%) | 10.43 | 101.66 | 101.62 |
| EPS (₹) | 3.98 | 1.53 | -3.12 |
| ROE (%) | 47.19 | -2,080.85 | -167.00 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 16.38 | 85.49 | 78.40 |
| Debt to Equity | 0.51 | -9.64 | -2.15 |
The market Capitalisation of Trident Lifeline IPO is ₹ 116.14 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Trident Lifeline IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Trident Lifeline IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Trident Lifeline IPO is ₹ 116.14 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Trident Lifeline IPO has a Price-to-Earnings (PE) ratio of 51.53 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Trident Lifeline IPO reported revenue of ₹ 22.37 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Trident Lifeline IPO provide insights into sales growth, market demand, and business scalability.
Trident Lifeline recorded an EBITDA of ₹ 2.76 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Trident Lifeline Profit After Tax (PAT) is ₹ 2.27 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 21.77 Cr.
EBITDA Margin:
12.68
%
Net Worth: ₹ 4.81 Cr.
Market Capitalisation:
₹ 116.14 Cr.
P/E:
51.53 times
P/BV: 2.89 times
EV/EBITDA: 42.92 times
Trident Lifeline operates in Pharmaceutical and Pharmaceutical Business. The Issue is listed on BSE SME in Oct, 2022. Trident Lifeline IPO size was 35.34 with Issue price of 101.00 .
Merchant Banker(s) of Trident Lifeline IPO: Beeline Capital Advisors Private Limited
Trident Lifeline IPO subscription was 1.34 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Trident Lifeline IPO listed at a listing price of 108.15 against the offer price of 101.00.
The current market price of Trident Lifeline is 309.50.
Why Us?
